AVAV: 31% | AeroVironment shares are trading higher after the company reported better-than-expected Q4 financial results.

 

GMAB: 8% | Genmab shares are trading higher after the company announced topline results from the Phase 3 EPCORE DLBCL-4 trial. The trial met its primary objective.

 

CNXC: -25% | Concentrix shares are trading lower after the company reported worse-than-expected Q2 financial results and issued Q3 guidance below estimates. Also, the company cut its FY26 guidance below estimates.